Association between phosphodiesterase 4D gene and ischaemic stroke

Background: An association between the phosphodiesterase 4D (PDE4D) gene and risk of ischaemic stroke in an Icelandic population has been suggested by the deCODE group. Methods: A case–control study of 151 hospitalised patients with first-ever ischaemic stroke and 164 randomly selected age-matched a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of neurology, neurosurgery and psychiatry neurosurgery and psychiatry, 2006-09, Vol.77 (9), p.1067-1069
Hauptverfasser: Staton, J M, Sayer, M S, Hankey, G J, Attia, J, Thakkinstian, A, Yi, Q, Cole, V J, Baker, R, Eikelboom, J W
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1069
container_issue 9
container_start_page 1067
container_title Journal of neurology, neurosurgery and psychiatry
container_volume 77
creator Staton, J M
Sayer, M S
Hankey, G J
Attia, J
Thakkinstian, A
Yi, Q
Cole, V J
Baker, R
Eikelboom, J W
description Background: An association between the phosphodiesterase 4D (PDE4D) gene and risk of ischaemic stroke in an Icelandic population has been suggested by the deCODE group. Methods: A case–control study of 151 hospitalised patients with first-ever ischaemic stroke and 164 randomly selected age-matched and sex-matched community controls was conducted. PDE4D genotypes for the six single-nucleotide polymorphisms (SNPs) previously reported to be independently associated with stroke were determined, common haplotypes were inferred using the expectation-maximisation algorithm, and SNP and haplotype associations with stroke were examined. A meta-analysis of published studies examining the association between PDE4D and stroke was also carried out. Results: Our study of Australian patients with stroke showed an independent association between ischaemic stroke and PDE4D SNP 89 (CC: odds ratio (OR) 5.55, 95% confidence interval (CI) 1.02 to 30.19; CA: OR 1.68, 95% CI 0.96 to 2.96; AA: OR 1 (reference)), SNP 87 (CC: OR 2.13, 95% CI 1.08 to 4.20; TC: OR 1.64, 95% CI 0.89 to 3.00; TT: OR 1 (reference)) and SNP 83 (TT: OR 2.16, 95% CI 1.08 to 4.32; TC: OR 1.37, 95% CI 0.77 to 2.43; CC: OR 1 (reference)), and between ischaemic stroke and PDE4D haplotypes at SNP 89–87–83 (A–C–C: OR 2.13, 95% CI 1.15 to 3.96; C–C–T: OR 2.25, 95% CI 1.29 to 3.92), but no association between ischaemic stroke and PDE4D SNP 56, SNP 45 or SNP 41, or with PDE4D haplotypes at SNP 56–45–41. A meta-analysis of nine case–control studies (including our current results) of 3808 stroke cases and 4377 controls confirmed a significant association between stroke and PDE SNP 87 (pooled p = 0.002), SNP 83 (0.003) and SNP 41 (0.003). However, there was statistical heterogeneity (p
doi_str_mv 10.1136/jnnp.2006.092106
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2077747</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4023835961</sourcerecordid><originalsourceid>FETCH-LOGICAL-b557t-3fa1e17ea789d0057e0f109e667d0ce98110e84a87abd57ef606d764985941853</originalsourceid><addsrcrecordid>eNqFkctv1DAQxi0EokvhzglFQnBBWcZx_LpUahfoIlU8JEC9WU4y6Xq7sRc7y-O_x6usWuBSSyMfvt-M5puPkKcU5pQy8Xrt_XZeAYg56IqCuEdmtBaqZAwu75MZQFWVDDgckUcprWH_lH5IjqjQtJacz8jZaUqhdXZ0wRcNjj8RfbFdhZSrc5hGjDZhUb8prtBjYX1XuNSuLA6uLdIYwzU-Jg96u0n45PAfk6_v3n5ZLMuLj-fvF6cXZcO5HEvWW4pUopVKdwBcIvQUNAohO2hRK0oBVW2VtE2X1V6A6KSoteK6poqzY3Iyzd3umgG7Fv0Y7cZsoxts_G2CdeZfxbuVuQo_TAVSylrmAS8PA2L4vsvezJC94GZjPYZdMkJJXkHN7wSpZlRLUWXw-X_gOuyiz1cwVCpa1SAZyxRMVBtDShH7m50pmH2OZp-j2edophxzy7O_vd42HILLwIsDYFNrN320vnXpllNQyVyZKyfO5Sh_3eg2XhshmeTmw7eF-bRcXrLzs89GZ_7VxDfD-u41_wA7A8Jj</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1781240733</pqid></control><display><type>article</type><title>Association between phosphodiesterase 4D gene and ischaemic stroke</title><source>MEDLINE</source><source>BMJ Journals - NESLi2</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Staton, J M ; Sayer, M S ; Hankey, G J ; Attia, J ; Thakkinstian, A ; Yi, Q ; Cole, V J ; Baker, R ; Eikelboom, J W</creator><creatorcontrib>Staton, J M ; Sayer, M S ; Hankey, G J ; Attia, J ; Thakkinstian, A ; Yi, Q ; Cole, V J ; Baker, R ; Eikelboom, J W</creatorcontrib><description>Background: An association between the phosphodiesterase 4D (PDE4D) gene and risk of ischaemic stroke in an Icelandic population has been suggested by the deCODE group. Methods: A case–control study of 151 hospitalised patients with first-ever ischaemic stroke and 164 randomly selected age-matched and sex-matched community controls was conducted. PDE4D genotypes for the six single-nucleotide polymorphisms (SNPs) previously reported to be independently associated with stroke were determined, common haplotypes were inferred using the expectation-maximisation algorithm, and SNP and haplotype associations with stroke were examined. A meta-analysis of published studies examining the association between PDE4D and stroke was also carried out. Results: Our study of Australian patients with stroke showed an independent association between ischaemic stroke and PDE4D SNP 89 (CC: odds ratio (OR) 5.55, 95% confidence interval (CI) 1.02 to 30.19; CA: OR 1.68, 95% CI 0.96 to 2.96; AA: OR 1 (reference)), SNP 87 (CC: OR 2.13, 95% CI 1.08 to 4.20; TC: OR 1.64, 95% CI 0.89 to 3.00; TT: OR 1 (reference)) and SNP 83 (TT: OR 2.16, 95% CI 1.08 to 4.32; TC: OR 1.37, 95% CI 0.77 to 2.43; CC: OR 1 (reference)), and between ischaemic stroke and PDE4D haplotypes at SNP 89–87–83 (A–C–C: OR 2.13, 95% CI 1.15 to 3.96; C–C–T: OR 2.25, 95% CI 1.29 to 3.92), but no association between ischaemic stroke and PDE4D SNP 56, SNP 45 or SNP 41, or with PDE4D haplotypes at SNP 56–45–41. A meta-analysis of nine case–control studies (including our current results) of 3808 stroke cases and 4377 controls confirmed a significant association between stroke and PDE SNP 87 (pooled p = 0.002), SNP 83 (0.003) and SNP 41 (0.003). However, there was statistical heterogeneity (p&lt;0.1) among the studies in the direction of association for each of the individual SNPs tested. Conclusions: Our results and the pooled analyses from all the studies indicate a strong association between PDE4D and ischaemic stroke. This strengthens the evidence that PDE4D plays a key part in the pathogenesis of ischaemic stroke. Heterogeneity among the studies in the direction of association between individual SNPs and stroke suggests that the SNPs tested are in linkage disequilibrium with the causal allele(s).</description><identifier>ISSN: 0022-3050</identifier><identifier>EISSN: 1468-330X</identifier><identifier>DOI: 10.1136/jnnp.2006.092106</identifier><identifier>PMID: 16914755</identifier><identifier>CODEN: JNNPAU</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd</publisher><subject>3',5'-Cyclic-AMP Phosphodiesterases - genetics ; Age ; Aged ; Biological and medical sciences ; Brain Ischemia - genetics ; Case-Control Studies ; Confidence intervals ; Cyclic Nucleotide Phosphodiesterases, Type 3 ; Cyclic Nucleotide Phosphodiesterases, Type 4 ; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases ; Diabetes ; Female ; Genes ; Genetic Predisposition to Disease ; Haplotypes ; Heart attacks ; Humans ; Hypertension ; Linkage Disequilibrium ; Male ; Medical sciences ; Meta-analysis ; Middle Aged ; Neurology ; Patients ; PDE4D ; phosphodiesterase 4D ; Polymorphism, Single Nucleotide ; Short Report ; single-nucleotide polymorphism ; SNP ; Stroke ; Stroke - genetics ; Studies ; Systematic review ; Vascular diseases and vascular malformations of the nervous system</subject><ispartof>Journal of neurology, neurosurgery and psychiatry, 2006-09, Vol.77 (9), p.1067-1069</ispartof><rights>Copyright 2006 Journal of Neurology Neurosurgery and Psychiatry</rights><rights>2006 INIST-CNRS</rights><rights>Copyright: 2006 Copyright 2006 Journal of Neurology Neurosurgery and Psychiatry</rights><rights>Copyright © 2006 BMJ Publishing Group</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b557t-3fa1e17ea789d0057e0f109e667d0ce98110e84a87abd57ef606d764985941853</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://jnnp.bmj.com/content/77/9/1067.full.pdf$$EPDF$$P50$$Gbmj$$H</linktopdf><linktohtml>$$Uhttps://jnnp.bmj.com/content/77/9/1067.full$$EHTML$$P50$$Gbmj$$H</linktohtml><link.rule.ids>114,115,230,314,724,777,781,882,3183,23552,27905,27906,53772,53774,77349,77380</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18027802$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16914755$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Staton, J M</creatorcontrib><creatorcontrib>Sayer, M S</creatorcontrib><creatorcontrib>Hankey, G J</creatorcontrib><creatorcontrib>Attia, J</creatorcontrib><creatorcontrib>Thakkinstian, A</creatorcontrib><creatorcontrib>Yi, Q</creatorcontrib><creatorcontrib>Cole, V J</creatorcontrib><creatorcontrib>Baker, R</creatorcontrib><creatorcontrib>Eikelboom, J W</creatorcontrib><title>Association between phosphodiesterase 4D gene and ischaemic stroke</title><title>Journal of neurology, neurosurgery and psychiatry</title><addtitle>J Neurol Neurosurg Psychiatry</addtitle><description>Background: An association between the phosphodiesterase 4D (PDE4D) gene and risk of ischaemic stroke in an Icelandic population has been suggested by the deCODE group. Methods: A case–control study of 151 hospitalised patients with first-ever ischaemic stroke and 164 randomly selected age-matched and sex-matched community controls was conducted. PDE4D genotypes for the six single-nucleotide polymorphisms (SNPs) previously reported to be independently associated with stroke were determined, common haplotypes were inferred using the expectation-maximisation algorithm, and SNP and haplotype associations with stroke were examined. A meta-analysis of published studies examining the association between PDE4D and stroke was also carried out. Results: Our study of Australian patients with stroke showed an independent association between ischaemic stroke and PDE4D SNP 89 (CC: odds ratio (OR) 5.55, 95% confidence interval (CI) 1.02 to 30.19; CA: OR 1.68, 95% CI 0.96 to 2.96; AA: OR 1 (reference)), SNP 87 (CC: OR 2.13, 95% CI 1.08 to 4.20; TC: OR 1.64, 95% CI 0.89 to 3.00; TT: OR 1 (reference)) and SNP 83 (TT: OR 2.16, 95% CI 1.08 to 4.32; TC: OR 1.37, 95% CI 0.77 to 2.43; CC: OR 1 (reference)), and between ischaemic stroke and PDE4D haplotypes at SNP 89–87–83 (A–C–C: OR 2.13, 95% CI 1.15 to 3.96; C–C–T: OR 2.25, 95% CI 1.29 to 3.92), but no association between ischaemic stroke and PDE4D SNP 56, SNP 45 or SNP 41, or with PDE4D haplotypes at SNP 56–45–41. A meta-analysis of nine case–control studies (including our current results) of 3808 stroke cases and 4377 controls confirmed a significant association between stroke and PDE SNP 87 (pooled p = 0.002), SNP 83 (0.003) and SNP 41 (0.003). However, there was statistical heterogeneity (p&lt;0.1) among the studies in the direction of association for each of the individual SNPs tested. Conclusions: Our results and the pooled analyses from all the studies indicate a strong association between PDE4D and ischaemic stroke. This strengthens the evidence that PDE4D plays a key part in the pathogenesis of ischaemic stroke. Heterogeneity among the studies in the direction of association between individual SNPs and stroke suggests that the SNPs tested are in linkage disequilibrium with the causal allele(s).</description><subject>3',5'-Cyclic-AMP Phosphodiesterases - genetics</subject><subject>Age</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Brain Ischemia - genetics</subject><subject>Case-Control Studies</subject><subject>Confidence intervals</subject><subject>Cyclic Nucleotide Phosphodiesterases, Type 3</subject><subject>Cyclic Nucleotide Phosphodiesterases, Type 4</subject><subject>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</subject><subject>Diabetes</subject><subject>Female</subject><subject>Genes</subject><subject>Genetic Predisposition to Disease</subject><subject>Haplotypes</subject><subject>Heart attacks</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Linkage Disequilibrium</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Meta-analysis</subject><subject>Middle Aged</subject><subject>Neurology</subject><subject>Patients</subject><subject>PDE4D</subject><subject>phosphodiesterase 4D</subject><subject>Polymorphism, Single Nucleotide</subject><subject>Short Report</subject><subject>single-nucleotide polymorphism</subject><subject>SNP</subject><subject>Stroke</subject><subject>Stroke - genetics</subject><subject>Studies</subject><subject>Systematic review</subject><subject>Vascular diseases and vascular malformations of the nervous system</subject><issn>0022-3050</issn><issn>1468-330X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqFkctv1DAQxi0EokvhzglFQnBBWcZx_LpUahfoIlU8JEC9WU4y6Xq7sRc7y-O_x6usWuBSSyMfvt-M5puPkKcU5pQy8Xrt_XZeAYg56IqCuEdmtBaqZAwu75MZQFWVDDgckUcprWH_lH5IjqjQtJacz8jZaUqhdXZ0wRcNjj8RfbFdhZSrc5hGjDZhUb8prtBjYX1XuNSuLA6uLdIYwzU-Jg96u0n45PAfk6_v3n5ZLMuLj-fvF6cXZcO5HEvWW4pUopVKdwBcIvQUNAohO2hRK0oBVW2VtE2X1V6A6KSoteK6poqzY3Iyzd3umgG7Fv0Y7cZsoxts_G2CdeZfxbuVuQo_TAVSylrmAS8PA2L4vsvezJC94GZjPYZdMkJJXkHN7wSpZlRLUWXw-X_gOuyiz1cwVCpa1SAZyxRMVBtDShH7m50pmH2OZp-j2edophxzy7O_vd42HILLwIsDYFNrN320vnXpllNQyVyZKyfO5Sh_3eg2XhshmeTmw7eF-bRcXrLzs89GZ_7VxDfD-u41_wA7A8Jj</recordid><startdate>20060901</startdate><enddate>20060901</enddate><creator>Staton, J M</creator><creator>Sayer, M S</creator><creator>Hankey, G J</creator><creator>Attia, J</creator><creator>Thakkinstian, A</creator><creator>Yi, Q</creator><creator>Cole, V J</creator><creator>Baker, R</creator><creator>Eikelboom, J W</creator><general>BMJ Publishing Group Ltd</general><general>BMJ</general><general>BMJ Publishing Group LTD</general><general>BMJ Group</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M2P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20060901</creationdate><title>Association between phosphodiesterase 4D gene and ischaemic stroke</title><author>Staton, J M ; Sayer, M S ; Hankey, G J ; Attia, J ; Thakkinstian, A ; Yi, Q ; Cole, V J ; Baker, R ; Eikelboom, J W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b557t-3fa1e17ea789d0057e0f109e667d0ce98110e84a87abd57ef606d764985941853</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>3',5'-Cyclic-AMP Phosphodiesterases - genetics</topic><topic>Age</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Brain Ischemia - genetics</topic><topic>Case-Control Studies</topic><topic>Confidence intervals</topic><topic>Cyclic Nucleotide Phosphodiesterases, Type 3</topic><topic>Cyclic Nucleotide Phosphodiesterases, Type 4</topic><topic>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</topic><topic>Diabetes</topic><topic>Female</topic><topic>Genes</topic><topic>Genetic Predisposition to Disease</topic><topic>Haplotypes</topic><topic>Heart attacks</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Linkage Disequilibrium</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Meta-analysis</topic><topic>Middle Aged</topic><topic>Neurology</topic><topic>Patients</topic><topic>PDE4D</topic><topic>phosphodiesterase 4D</topic><topic>Polymorphism, Single Nucleotide</topic><topic>Short Report</topic><topic>single-nucleotide polymorphism</topic><topic>SNP</topic><topic>Stroke</topic><topic>Stroke - genetics</topic><topic>Studies</topic><topic>Systematic review</topic><topic>Vascular diseases and vascular malformations of the nervous system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Staton, J M</creatorcontrib><creatorcontrib>Sayer, M S</creatorcontrib><creatorcontrib>Hankey, G J</creatorcontrib><creatorcontrib>Attia, J</creatorcontrib><creatorcontrib>Thakkinstian, A</creatorcontrib><creatorcontrib>Yi, Q</creatorcontrib><creatorcontrib>Cole, V J</creatorcontrib><creatorcontrib>Baker, R</creatorcontrib><creatorcontrib>Eikelboom, J W</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Science Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of neurology, neurosurgery and psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Staton, J M</au><au>Sayer, M S</au><au>Hankey, G J</au><au>Attia, J</au><au>Thakkinstian, A</au><au>Yi, Q</au><au>Cole, V J</au><au>Baker, R</au><au>Eikelboom, J W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Association between phosphodiesterase 4D gene and ischaemic stroke</atitle><jtitle>Journal of neurology, neurosurgery and psychiatry</jtitle><addtitle>J Neurol Neurosurg Psychiatry</addtitle><date>2006-09-01</date><risdate>2006</risdate><volume>77</volume><issue>9</issue><spage>1067</spage><epage>1069</epage><pages>1067-1069</pages><issn>0022-3050</issn><eissn>1468-330X</eissn><coden>JNNPAU</coden><abstract>Background: An association between the phosphodiesterase 4D (PDE4D) gene and risk of ischaemic stroke in an Icelandic population has been suggested by the deCODE group. Methods: A case–control study of 151 hospitalised patients with first-ever ischaemic stroke and 164 randomly selected age-matched and sex-matched community controls was conducted. PDE4D genotypes for the six single-nucleotide polymorphisms (SNPs) previously reported to be independently associated with stroke were determined, common haplotypes were inferred using the expectation-maximisation algorithm, and SNP and haplotype associations with stroke were examined. A meta-analysis of published studies examining the association between PDE4D and stroke was also carried out. Results: Our study of Australian patients with stroke showed an independent association between ischaemic stroke and PDE4D SNP 89 (CC: odds ratio (OR) 5.55, 95% confidence interval (CI) 1.02 to 30.19; CA: OR 1.68, 95% CI 0.96 to 2.96; AA: OR 1 (reference)), SNP 87 (CC: OR 2.13, 95% CI 1.08 to 4.20; TC: OR 1.64, 95% CI 0.89 to 3.00; TT: OR 1 (reference)) and SNP 83 (TT: OR 2.16, 95% CI 1.08 to 4.32; TC: OR 1.37, 95% CI 0.77 to 2.43; CC: OR 1 (reference)), and between ischaemic stroke and PDE4D haplotypes at SNP 89–87–83 (A–C–C: OR 2.13, 95% CI 1.15 to 3.96; C–C–T: OR 2.25, 95% CI 1.29 to 3.92), but no association between ischaemic stroke and PDE4D SNP 56, SNP 45 or SNP 41, or with PDE4D haplotypes at SNP 56–45–41. A meta-analysis of nine case–control studies (including our current results) of 3808 stroke cases and 4377 controls confirmed a significant association between stroke and PDE SNP 87 (pooled p = 0.002), SNP 83 (0.003) and SNP 41 (0.003). However, there was statistical heterogeneity (p&lt;0.1) among the studies in the direction of association for each of the individual SNPs tested. Conclusions: Our results and the pooled analyses from all the studies indicate a strong association between PDE4D and ischaemic stroke. This strengthens the evidence that PDE4D plays a key part in the pathogenesis of ischaemic stroke. Heterogeneity among the studies in the direction of association between individual SNPs and stroke suggests that the SNPs tested are in linkage disequilibrium with the causal allele(s).</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd</pub><pmid>16914755</pmid><doi>10.1136/jnnp.2006.092106</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-3050
ispartof Journal of neurology, neurosurgery and psychiatry, 2006-09, Vol.77 (9), p.1067-1069
issn 0022-3050
1468-330X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2077747
source MEDLINE; BMJ Journals - NESLi2; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects 3',5'-Cyclic-AMP Phosphodiesterases - genetics
Age
Aged
Biological and medical sciences
Brain Ischemia - genetics
Case-Control Studies
Confidence intervals
Cyclic Nucleotide Phosphodiesterases, Type 3
Cyclic Nucleotide Phosphodiesterases, Type 4
Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases
Diabetes
Female
Genes
Genetic Predisposition to Disease
Haplotypes
Heart attacks
Humans
Hypertension
Linkage Disequilibrium
Male
Medical sciences
Meta-analysis
Middle Aged
Neurology
Patients
PDE4D
phosphodiesterase 4D
Polymorphism, Single Nucleotide
Short Report
single-nucleotide polymorphism
SNP
Stroke
Stroke - genetics
Studies
Systematic review
Vascular diseases and vascular malformations of the nervous system
title Association between phosphodiesterase 4D gene and ischaemic stroke
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T11%3A36%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Association%20between%20phosphodiesterase%204D%20gene%20and%20ischaemic%20stroke&rft.jtitle=Journal%20of%20neurology,%20neurosurgery%20and%20psychiatry&rft.au=Staton,%20J%20M&rft.date=2006-09-01&rft.volume=77&rft.issue=9&rft.spage=1067&rft.epage=1069&rft.pages=1067-1069&rft.issn=0022-3050&rft.eissn=1468-330X&rft.coden=JNNPAU&rft_id=info:doi/10.1136/jnnp.2006.092106&rft_dat=%3Cproquest_pubme%3E4023835961%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1781240733&rft_id=info:pmid/16914755&rfr_iscdi=true